积极降低血压是危险的：J 曲线——争论的反面观点。 - Suppr

Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement.

作者信息

Verdecchia Paolo, Angeli Fabio, Mazzotta Giovanni, Garofoli Marta, Reboldi Gianpaolo

出版信息

Hypertension. 2014 Jan;63(1):37-40. doi: 10.1161/01.hyp.0000439102.43479.43.

DOI:10.1161/01.hyp.0000439102.43479.43

PMID:24336630

Abstract

摘要

相似文献

Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement.

Hypertension. 2014 Jan;63(1):37-40. doi: 10.1161/01.hyp.0000439102.43479.43.

Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the arguement.

Hypertension. 2014 Jan;63(1):29-36. doi: 10.1161/01.hyp.0000441190.09494.e9.

Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve.

Eur Heart J. 2010 Dec;31(23):2837-40. doi: 10.1093/eurheartj/ehq281. Epub 2010 Oct 27.

Should reducing nocturnal blood pressure be a therapeutic target in CKD? The time is ripe for a clinical outcomes trial.

Am J Kidney Dis. 2007 Dec;50(6):901-3. doi: 10.1053/j.ajkd.2007.10.005.

[How much should blood pressure be reduced? Is there a J-shaped relationship between lowered blood pressure and cardiovascular morbidity?].

Harefuah. 1997 Nov 16;133(10):462-8.

Blood pressure lowering or selection of antihypertensive agent: which is more important?

Nephrol Dial Transplant. 2006 Apr;21(4):843-5. doi: 10.1093/ndt/gfk025. Epub 2005 Dec 29.

Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.

Cell Mol Biol (Noisy-le-grand). 2005 Nov 8;51(6):521-3.

Treatment of stage I hypertension and development of renal dysfunction.

J Hum Hypertens. 2001 Feb;15(2):81-4. doi: 10.1038/sj.jhh.1001135.

Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

Am J Kidney Dis. 2007 Dec;50(6):908-17. doi: 10.1053/j.ajkd.2007.07.020.

Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.

South Med J. 2009 Dec;102(12):1201-2. doi: 10.1097/SMJ.0b013e3181bef7bd.

引用本文的文献

Intensive blood pressure-lowering treatment to prevent cardiovascular events in patients with diabetes: a systematic review and meta-analysis.

Hypertens Res. 2025 Apr 23. doi: 10.1038/s41440-025-02209-9.

Blood pressure targets for hypertension in people with chronic renal disease.

Cochrane Database Syst Rev. 2024 Oct 15;10(10):CD008564. doi: 10.1002/14651858.CD008564.pub3.

Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study.

Hypertens Res. 2024 Jun;47(6):1546-1554. doi: 10.1038/s41440-024-01593-y. Epub 2024 Feb 14.

mRNA Metabolism and Hypertension.

Biomedicines. 2023 Jan 3;11(1):118. doi: 10.3390/biomedicines11010118.

Are U-shaped relationships between risk factors and outcomes artifactual?

J Diabetes. 2022 Dec;14(12):815-821. doi: 10.1111/1753-0407.13335. Epub 2022 Dec 8.

Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.

Cochrane Database Syst Rev. 2022 Nov 18;11(11):CD010315. doi: 10.1002/14651858.CD010315.pub5.

2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Acta Cardiol Sin. 2022 May;38(3):225-325. doi: 10.6515/ACS.202205_38(3).20220321A.

Advances in the Treatment Strategies in Hypertension: Present and Future.

J Cardiovasc Dev Dis. 2022 Mar 3;9(3):72. doi: 10.3390/jcdd9030072.

Association of Mid- to Late-Life Blood Pressure Patterns With Risk of Subsequent Coronary Heart Disease and Death.

Front Cardiovasc Med. 2021 Feb 15;8:632514. doi: 10.3389/fcvm.2021.632514. eCollection 2021.

Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.

Cochrane Database Syst Rev. 2020 Sep 9;9(9):CD010315. doi: 10.1002/14651858.CD010315.pub4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献